Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Antenatal screening for fetal trisomies using microarray-based cell-free DNA testing : a systematic review and meta-analysis

Tools
- Tools
+ Tools

Geppert, Julia, Stinton, Chris, Johnson, Samantha Ann, Clarke, Aileen, Grammatopoulos, Dimitris and Taylor-Phillips, Sian (2020) Antenatal screening for fetal trisomies using microarray-based cell-free DNA testing : a systematic review and meta-analysis. Prenatal Diagnosis, 40 (4). pp. 454-462. doi:10.1002/pd.5621

[img] PDF
Geppert 2019_Antenatal screening for fetal trisomies using microarray-based cfDNA testing.pdf - Published Version
Embargoed item. Restricted access to Repository staff only - Requires a PDF viewer.

Download (1486Kb)
Official URL: https://doi.org/10.1002/pd.5621

Request Changes to record.

Abstract

Objective
To evaluate the test accuracy of non‐invasive prenatal testing (NIPT) for fetal trisomy 21, 18, and 13 using cell‐free (cf) DNA analysis in maternal plasma with microarray quantitation.

Method
Systematic review and meta‐analysis. Searches in MEDLINE, Pre‐MEDLINE, EMBASE, Web of Science, and the Cochrane Library to 09.07.2018.

Results
Five studies analyzing 3074 samples, including 187 trisomy 21, 43 trisomy 18, and 19 trisomy 13 cases, were identified. Risk of bias was high in all studies, introduced particularly by exclusions from analysis and by the role of the sponsor. Sensitivity of microarray‐based cfDNA testing was 99.5% (95%CI 96.3%‐99.9%) for trisomy 21, 97.7% (95%CI 87.9%‐99.6%) for trisomy 18, and 100% (95%CI 83.2%‐100%) for trisomy 13. Specificity was 100% (95% CI 99.87%‐100%) for trisomy 21, 99.97% (95%CI 99.81%‐99.99%) for trisomy 18, and 99.97% (95%CI 99.81%‐99.99%) for trisomy 13. Pooled test failure rate was 1.1%. A direct comparison of microarray‐ and sequencing‐based cfDNA found equivalent test accuracy.

Conclusion
Included studies suggest that NIPT using microarray‐based cfDNA testing has high sensitivity and specificity for detecting fetal trisomy 21, 18, and 13. However, the evidence base is small and at high risk of bias.

Item Type: Journal Article
Subjects: R Medicine > RZ Other systems of medicine
Divisions: Faculty of Medicine > Warwick Medical School > Health Sciences
Administration > Library
Faculty of Medicine > Warwick Medical School > Health Sciences > Population, Evidence & Technologies (PET)
Faculty of Medicine > Warwick Medical School
Journal or Publication Title: Prenatal Diagnosis
Publisher: John Wiley & Sons Ltd.
ISSN: 0197-3851
Official Date: March 2020
Dates:
DateEvent
March 2020Published
13 December 2019Available
31 October 2019Accepted
19 July 2019Submitted
Volume: 40
Number: 4
Page Range: pp. 454-462
DOI: 10.1002/pd.5621
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Restricted or Subscription Access

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item
twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us